Closantel or its saltsPDL |
for veterinary use, including but not limited to closantel sodium
|
I |
AUG / 16 |
Clotiazepam and any salt thereofTS |
|
I |
JUN / 02 |
Clotrimazole and its salts.. |
for human use in preparations for topical use |
U |
DEC / 13 |
Clotrimazole or its saltsPDL |
for human use, except in preparations for topical or vaginal use
|
I |
DEC / 13 |
Clotrimazole or its salts. |
for human use in preparations for intra-vaginal use
|
III |
DEC / 13 |
Clozapine or its saltsPDL |
|
I |
DEC / 13 |
Coal tar |
in concentrations of more than 10% |
II |
SEP / 98 |
Coal tar. |
in concentrations up to and including 10% |
U |
|
Cobicistat or its saltsPDL |
|
I |
DEC / 18 |
Cobimetinib or its saltsPDL |
|
I |
AUG / 16 |
Coca (Erythroxylum), its preparations, derivatives, alkaloids and saltsN |
Including: Coca leaves; Cocaine; Ecgonine; but not including 123l-ioflupane
|
I |
JUN / 02 |
Codeine and its salts |
in preparations exempted from the Regulations to the Controlled Drugs and Substances Act |
II |
SEP / 98 |
ColchicinePDL |
|
I |
DEC / 13 |
Colesevelam or its saltsPDL |
including but not limited to colesevelam hydrochloride
|
I |
DEC / 13 |
Colestipol or its saltsPDL |
|
I |
DEC / 13 |
Colfosceril or its derivativesPDL |
|
I |
DEC / 13 |
Colistin or its salt or derivativesPDL |
including but not limited to colistimethate
|
I |
DEC / 13 |
CollagenasePDL |
when recommended for the debridement of severe burns and skin ulcers
|
I |
DEC / 13 |
Copper chloride (cupric chloride) in injectable form for parenteral nutrition |
|
I |
JAN / 03 |
Copper sulfate in injectable form for parenteral nutrition |
|
I |
JAN / 03 |
CrisaborolePDL |
|
I |
JUL / 18 |
Crizotinib or its salts or derivativesPDL |
|
I |
DEC / 13 |
Cromoglicic (cromoglycic) acid or its saltsPDL |
except sodium cromoglicate (cromoglycate) in solutions for ophthalmic or nasal use in concentrations of 2% or less [*see sodium cromoglicate (cromoglycate)]
|
I |
DEC / 13 |
Crotamiton |
|
II |
SEP / 98 |
Cyclandelate |
|
II |
SEP / 98 |
Cyclazocine and its salts |
|
II |
SEP / 98 |
CyclizinePDL |
for human use
|
I |
DEC / 13 |
Cyclobenzaprine or its saltsPDL |
|
I |
DEC / 13 |
Cyclomethacaine and its salts |
for ophthalmic or parenteral use |
II |
SEP / 98 |
Cyclopentamine and its salts |
|
II |
SEP / 98 |
Cyclopentolate or its salts |
except in products for ophthalmic or parenteral use |
II |
SEP / 98 |
Cyclopentolate or its saltsPDL |
in preparations for parenteral or ophthalmic use, except when sold for use in diagnostic procedures to an optometrist registered in a province of Canada
|
I |
DEC / 13 |
CyclophosphamidePDL |
|
I |
DEC / 13 |
CycloserinePDL |
|
I |
DEC / 13 |
CyclosporinePDL |
including but not limited to ciclosporin
|
I |
DEC / 13 |
Cyproheptadine and its salts |
|
II |
SEP / 98 |
Cyproterone acetatePDL |
including but not limited to cyproterone acetate
|
I |
DEC / 13 |
Cysteamine (Mercaptamine) or its saltsPDL |
|
I |
AUG / 17 |
Cytarabine or its saltsPDL |
|
I |
DEC / 13 |
Cytomegalovirus immune globulins |
|
I |
FEB / 02 |
Dabigatran or its salts or derivativesPDL |
including but not limited to dabigatran etexilate
|
I |
DEC / 13 |
Dabrafenib or its saltsPDL |
|
I |
DEC / 13 |
DacarbazinePDL |
|
I |
DEC / 13 |
Daclatasvir or its saltsPDL |
|
I |
OCT / 15 |
DaclizumabPDL |
|
I |
DEC / 13 |
Daclizumab betaPDL |
|
I |
FEB / 17 |
Dacomitinib or its saltsPDL |
|
I |
MAR / 19 |
DactinomycinPDL |
|
I |
DEC / 13 |
Dalbavancin or its saltsPDL |
|
I |
OCT / 18 |
Dalfopristin or its saltsPDL |
|
I |
DEC / 13 |
Dalteparin or its saltsPDL |
|
I |
DEC / 13 |
Danaparoid or its salts or derivativesPDL |
|
I |
DEC / 13 |
DanazolPDL |
|
I |
DEC / 13 |
Danofloxacin or its saltsPDL |
|
I |
DEC / 13 |
Danthron |
|
III |
SEP / 98 |
Dantrolene or its saltsPDL |
|
I |
DEC / 13 |
Dapagliflozin or its derivativesPDL |
|
I |
MAR / 15 |
Dapiprazole or its saltsPDL |
|
I |
DEC / 13 |
DaptomycinPDL |
|
I |
DEC / 13 |
DaratumumabPDL |
|
I |
AUG / 16 |
Darifenacin or its saltsPDL |
|
I |
DEC / 13 |
DarolutamidePDL |
|
I |
JUL / 20 |
DarunavirPDL |
|
I |
DEC / 13 |
Dasabuvir or its saltsPDL |
|
I |
MAR / 15 |
DasatanibPDL |
|
I |
DEC / 13 |
Daunorubicin or its saltsPDL |
|
I |
DEC / 13 |
Debrisoquin or its saltsPDL |
|
I |
DEC / 13 |
Decitabine or its saltsPDL |
|
I |
FEB / 19 |
DeferasiroxPDL |
|
I |
DEC / 13 |
Deferiprone or its derivativesPDL |
|
I |
MAR / 15 |
Deferoxamine or its saltsPDL |
|
I |
DEC / 13 |
Defibrotide or its salts or derivativesPDL |
|
I |
SEP / 17 |
Degarelix or its salts or derivativesPDL |
|
I |
DEC / 13 |
Dehydrocholic acid and its salts |
|
III |
SEP / 98 |
Delavirdine or its saltsPDL |
|
I |
DEC / 13 |
DenosumabPDL |
|
I |
DEC / 13 |
Deoxycholic acid or its saltsPDL |
when used in an injectable form
|
I |
OCT / 15 |
Dequalinium chloridePDL |
when sold for the treatment of bacterial vaginosis
|
I |
NOV / 21 |
DeracoxibPDL |
|
I |
DEC / 13 |
Derquantel or its saltsPDL |
for veterinary use
|
I |
AUG / 16 |
Deserpidine or its alkaloids or saltsPDL |
|
I |
DEC / 13 |
DesfluranePDL |
|
I |
DEC / 13 |
Desipramine or its saltsPDL |
|
I |
DEC / 13 |
Desloratadine and its salts and preparations. |
in products marketed for adult use - 12 years and older
|
U |
SEP / 05 |
Desloratadine and its salts and preparations. |
in products marketed for paediatric use - under 12 years of age |
III |
SEP / 05 |
Desmopressin or its saltsPDL |
|
I |
DEC / 13 |
Desoxyribonuclease [pancreatic dornase] |
|
II |
SEP / 98 |
Desvenlafaxine or its saltsPDL |
including but not limited to desvenlafaxine succinate
|
I |
DEC / 13 |
Detomidine or its saltsPDL |
|
I |
DEC / 13 |
Dexbrompheniramine and its salts |
|
III |
SEP / 98 |
Dexchlorpheniramine and its salts |
|
III |
SEP / 98 |
Dexrazoxane or its saltsPDL |
|
I |
DEC / 13 |
Dextromethorphan and its salts |
except in oral dosage forms in package sizes containing no more than 300mg DM base or 409.3 DM hydrobromide |
III |
AUG / 02 |
Dextromethorphan and its salts. |
in oral dosage forms in package sizes containing no more than 300 mg DM base or 409.3 DM hydrobromide |
U |
AUG / 02 |
Dextrose |
in injectable form, when used as a sclerosing agent
|
II |
SEP / 98 |
Dextrose injection |
concentrated solutions for parenteral injection |
I |
JAN / 03 |
Diazoxide or its saltsPDL |
|
I |
DEC / 13 |
Dibotermin alfaPDL |
for veterinary use
|
I |
FEB / 14 |
Dichloroacetic acidPDL |
|
I |
DEC / 13 |
Diclofenac diethylamine |
For human use - when sold as a single medicinal ingredient for topical use on the skin in concentrations greater than 1.16% and less than or equal to 2.32% for not more than 7 days - in package sizes containing greater than 2.6g of diclofenac diethylamine
|
III |
JUL / 22 |